Exposure | Selection of SNPs | Method | #SNPs | IHD | Diabetes | ||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | ||||
Linoleic acid (% in total fatty acids) | Genome-wide significant and functionally relevant SNPs | PCA | 47 | 1.01 | 0.95 to 1.08 | 0.71 | 0.97 | 0.96 to 0.99 | < 0.001 |
Most significant SNPs | IVW* | 3 | 0.99 | 0.96 to 1.01 | 0.18 | 0.97 | 0.95 to 0.99 | 0.001 | |
All genome-wide significant SNPs | PCA | 167 | 1.00 | 0.96 to 1.05 | 0.92 | 0.98 | 0.96 to 0.99 | 0.001 | |
DPA (% in total fatty acids) | Most significant SNPs in GWAS of n-3 PUFA (rs780094 and rs3734398) | IVW†| 2 | 1.10 | 0.77 to 1.59 | 0.60 | 0.45 | 0.10 to 2.02 | 0.30 |